A detailed history of Farallon Capital Management LLC transactions in Liquidia Corp stock. As of the latest transaction made, Farallon Capital Management LLC holds 3,290,956 shares of LQDA stock, worth $33.4 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,290,956
Previous 2,055,000 60.14%
Holding current value
$33.4 Million
Previous $24.7 Million 33.45%
% of portfolio
0.17%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.9 - $14.11 $11 Million - $17.4 Million
1,235,956 Added 60.14%
3,290,956 $32.9 Million
Q1 2024

May 15, 2024

BUY
$11.35 - $16.73 $23.3 Million - $34.4 Million
2,055,000 New
2,055,000 $30.3 Million
Q3 2020

Nov 16, 2020

BUY
$4.34 - $8.28 $66,619 - $127,097
15,350 Added 0.83%
1,865,350 $9.18 Million
Q2 2020

Aug 14, 2020

BUY
$4.86 - $11.44 $8.99 Million - $21.2 Million
1,850,000 New
1,850,000 $15.6 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $653M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.